Terveystalo Oyj - Other information disclosed according to the rules of the Exchange

Terveystalo Plc applies for its shares to be listed on the Official List of Nasdaq Helsinki Ltd

TERVEYSTALO PLC STOCK EXCHANGE RELEASE       September 28, 2017 at 15:55 pm EET

NOT  FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN  WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY,  IN OR INTO AUSTRALIA, CANADA,  THE HONG KONG SPECIAL ADMINISTRATIVE
REGION  OF THE  PEOPLE'S REPUBLIC  OF CHINA,  JAPAN, SOUTH  AFRICA OR THE UNITED
STATES,  OR  ANY  OTHER  JURISDICTION  IN  WHICH  THE  RELEASE,  PUBLICATION  OR
DISTRIBUTION WOULD BE UNLAWFUL.

Terveystalo Plc applies for its shares to be listed on the Official List of
Nasdaq Helsinki Ltd

Terveystalo  Plc  ("Terveystalo"  or  the  "Company")  has today filed a listing
application  with Nasdaq  Helsinki Ltd  ("Helsinki Stock  Exchange") to list the
Company's  shares first  on the  Prelist and  then on  the Official  List of the
Helsinki  Stock Exchange. Trading in  the shares is expected  to commence on the
Prelist  of the Helsinki Stock Exchange on  or about October 11, 2017 and on the
Official List on or about October 13, 2017 under the share trading code "TTALO".

Terveystalo Plc
Communications

Further enquiries
Yrjö Närhinen, CEO, Terveystalo
yrjo.narhinen@terveystalo.com

Susanna Kinnari, SVP Communications, Marketing and Brand, Terveystalo
Tel. +358 (50) 5458333
susanna.kinnari@terveystalo.com

Kati Kaksonen, Director, Investor Relations & Finance Communications,
Terveystalo,
Tel. +358 50 3931561
kati.kaksonen@terveystalo.com

Distribution:
Nasdaq Helsinki Ltd
Principal media
www.terveystalo.com

Terveystalo in brief

Terveystalo is a leading private healthcare service provider in Finland offering
primary  and outpatient secondary healthcare  services to corporate, private and
public  sector  customers.  The  Company's  healthcare service offering includes
general  practice and  specialist medical  care, diagnostic services, outpatient
surgery,  dental services and  other adjacent services,  which together comprise
its integrated healthcare care chain. The Company also offers a suite of digital
healthcare services. Terveystalo is able to provide nationwide reach through its
approximately 180 clinics, covering all 20 of Finland's largest cities, together
with its digital platforms.

Terveystalo's  operations are driven  by its scale  and supported by centralized
functions  and standardized  operating practices.  At the  core of Terveystalo's
strategy  is  a  focus  on  providing  medical  quality  and  positive  customer
experiences,   maintaining   a   competent  and  satisfied  base  of  healthcare
professionals and developing a variety of customized digital tools.

In  2016, the Company had approximately 1.0 million individual customers as well
as  approximately  2.7 million  doctor  visits,  accounting for 12% of the total
doctor visits in Finland. The Company's customers are divided into three groups:
corporate  customers, who  the Company  partners with  to provide,  for example,
occupational  healthcare  services  to  their  employees,  private customers and
public  customers, who  the Company  partners with  to provide public healthcare
services   and   occupational   healthcare   services  to  municipal  employees.
Terveystalo  had approximately  4,445 employees (including  part-time employees)
and approximately 4,400 private practitioners as at June 30, 2017.

DISCLAIMER

This announcement does not constitute an offer for sale of, or a solicitation of
an  offer to  purchase or  subscribe for,  any securities  in the United States.
Securities  may not  be offered  or sold  in the  United States  unless they are
registered  or are  exempt from  registration under  the U.S.  Securities Act of
1933, as  amended.  The  information  contained  in  this  announcement  is  for
informational  purposes  only  and  does  not  purport  to  be full or complete.
Terveystalo  Plc (the "Company") does not intend to register any portion of this
offering  in the  United States  or to  conduct a  public offering in the United
States.  Copies  of  this  announcement  are  not  being,  and  should  not  be,
distributed in or sent into the United States.

It  may be  unlawful to  distribute this  announcement in certain jurisdictions.
This  announcement is not  for distribution in  Australia, Canada, the Hong Kong
special  administrative region of  the People's Republic  of China, Japan, South
Africa,  the United States or to  any other jurisdiction where such distribution
would  be unlawful. The information in  this announcement does not constitute an
offer of securities for sale in such jurisdictions.

In  the United  Kingdom, this  announcement is  for distribution  only to and is
directed  only  at  persons  who  (i)  have  professional  experience in matters
relating  to  investments  which  fall  within  Article  19(5) of  the Financial
Services  and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the
"Financial  Promotion Order"), (ii) are persons falling within Article 49(2)(a)
to  (d) ("high  net worth  companies, unincorporated  associations etc")  of the
Financial  Promotion  Order,  or  (iii)  are  persons  to  whom an invitation or
inducement to engage in investment activity (within the meaning of section 21 of
the  Financial Services  and Markets  Act 2000) in  connection with the issue or
sale  of any securities may  otherwise lawfully be communicated  or caused to be
communicated   (all  such  persons  together  being  referred  to  as  "relevant
persons").  This announcement is directed only  at relevant persons and must not
be acted on or relied on by persons who are not relevant persons. Any investment
or  investment activity to which this  announcement relates is available only to
relevant persons and will be engaged in only with relevant persons.

This announcement has been prepared on the basis that any offer of securities in
any  Member State of the  European Economic Area, other  than Finland, which has
implemented  the  Prospectus  Directive  (2003/71/EC,  as  amended, including by
Directive  2010/73/EU, the  "Prospectus  Directive")  (each,  a "Relevant Member
State") will be made pursuant to an exemption under the Prospectus Directive, as
implemented  in that  Relevant Member  State, from  the requirement to publish a
prospectus  for offers of securities. Accordingly any person making or intending
to  make any  offer in  that Relevant  Member State  of securities which are the
subject  of the offering  contemplated in this  announcement, may only  do so in
circumstances  in which no obligation arises for the Company or any of the joint
global  coordinators  to  publish  a  prospectus  pursuant  to  Article 3 of the
Prospectus  Directive or supplement  a prospectus pursuant  to Article 16 of the
Prospectus  Directive,  in  each  case,  in  relation to such offer. Neither the
Company  nor any  of the  Managers have  authorised, nor  do they authorise, the
making  of any offer of the securities through any financial intermediary, other
than  offers made by  the Managers which  constitute the final  placement of the
securities contemplated in this announcement. Neither the Company nor any of the
Managers  have authorised,  nor do  they authorise,  the making  of any offer of
securities in circumstances in which an obligation arises for the Company or any
Managers to publish or supplement a prospectus for such offer.

In  connection with the  contemplated IPO and  in accordance with all applicable
laws  and rules, EQT and Skandinaviska Enskilda Banken AB (publ) Helsinki Branch
(the  "Stabilizing Manager")  (or persons  acting on  its behalf) acting for the
account of the Managers, may agree that the selling shareholders shall grant the
Stabilizing  Manager  an  option  to  over-allot  shares or effect stabilization
transactions with a view to supporting the market price of the shares at a level
higher  than that  which might  otherwise prevail  (provided that  the aggregate
principal  number  of  shares  allotted  does  not  exceed  15% of the aggregate
principal  number  of  the  offer  shares  in  the  contemplated  IPO). However,
stabilization  action may not necessarily  occur and may cease  at any time, and
the  Stabilization Manager is not required  to enter into such transactions. Any
stabilization  action may begin on or after  the date of commencement of trading
of  the shares on the Helsinki Stock Exchange and, if begun, may be ended at any
time, but it must end no later than 30 days after that date.

This  announcement includes forward-looking  statements which include statements
regarding  the Company's business  strategy, financial condition, profitability,
results  of operations and market data, as well as other statements that are not
historical  facts.  Words  such  as  "believe,"  "anticipate," "plan," "expect,"
"target,"  "estimate," "project," "predict,"  "forecast," "guideline," "should,"
"aim,"  "continue," "could," "guidance," "may,"  "potential," "will," as well as
similar  expressions  and  the  negative  of  such  expressions  are intended to
identify  forward-looking  statements,  but  are  not  the  exclusive  means  of
identifying  these statements.  By their  nature, forward-looking statements are
subject  to numerous  factors, risks  and uncertainties  that could cause actual
outcomes  and results to  be materially different  from those projected. Readers
are  cautioned not to place undue  reliance on these forward-looking statements.
Except  for any ongoing obligation to  disclose material information as required
by  the applicable law, the Company does not have any intention or obligation to
publicly  update or revise  any forward-looking statements  after it distributes
this  announcement, whether  to reflect  any future  events or  circumstances or
otherwise.

This announcement is an advertisement and not a prospectus. Investors should not
subscribe  for  or  purchase  any  transferable  securities  referred to in this
announcement  except  on  the  basis  of  information  in  the  Finnish language
prospectus  (the  "Finnish  Prospectus")  or  the  offering  circular that is an
English  language translation of the  original Finnish Prospectus (the "Offering
Circular"), the Finnish Prospectus being intended to be published by the Company
in  due course in  connection with the  proposed admission of  its shares to the
official  list of the Helsinki Stock  Exchange. Copies of the Finnish Prospectus
will,  following its  publication, be  available from  the Company's  website at
www.terveystalo.com/IPO.  Any purchase of  shares in the  proposed IPO should be
made  solely on  the basis  of the  information contained  in the  final Finnish
Prospectus  to  be  issued  by  the  Company  in connection with the IPO. Before
investing  in any shares,  persons viewing this  announcement should ensure that
they  fully understand and accept the risks which will be set out in the Finnish
Prospectus  when published or in the  Offering Circular. The information in this
announcement  is for background purposes only and does not purport to be full or
complete. No reliance may be placed for any purpose on the information contained
in this announcement or its accuracy or completeness. This announcement does not
constitute  or form  part of  any offer  or invitation  to sell or issue, or any
solicitation  of any offer to purchase or  subscribe for any shares or any other
securities  nor shall it  (or any part  of it) or  the fact of its distribution,
form  the basis of, or  be relied on in  connection with, any contract therefor.
The information in this announcement is subject to change.

The IPO timetable, including the date of admission of the shares to the official
list  of  the  Helsinki  Stock  Exchange,  may  be  influenced  by  a  range  of
circumstances such as market conditions. There is no guarantee that the IPO will
proceed  and that the Listing will occur  and you should not base your financial
decisions on the Company's intentions in relation to the IPO and Listing at this
stage.  Acquiring investments to  which this announcement  relates may expose an
investor  to a significant  risk of losing  all or part  of the amount invested.
Persons  considering  making  such  an  investment  should consult an authorised
person  specialising in advising on such investments. This announcement does not
constitute a recommendation concerning the IPO. The value of shares can decrease
as  well as increase. Potential investors  should consult a professional adviser
as to the suitability of the IPO for the person concerned.

Carnegie  Investment Bank AB, Finland branch, Morgan Stanley & Co. International
plc,   Skandinaviska  Enskilda  Banken  AB  (publ)  Helsinki  Branch,  Jefferies
International  Limited and OP Corporate Bank  plc are acting exclusively for the
Company  and the  selling shareholders  and no  one else  in connection with the
contemplated  IPO and will not be responsible  to any other person for providing
the  protections afforded to clients of the  Managers or for providing advice in
relation  to the IPO or any other transaction, matter or arrangement referred to
in this document.

Lazard  & Co., Limited, which is authorised  and regulated in the United Kingdom
by  the Financial Conduct Authority, is  acting exclusively as financial adviser
to  the Company and no one else in connection with the possible IPO and will not
be  responsible to anyone  other than the  Company for providing the protections
afforded  to  clients  of  Lazard  &  Co.,  Limited  nor for providing advice in
relation  to  the  possible  IPO  or  any  other  matters  referred  to  in this
announcement.  Neither Lazard & Co.,  Limited nor any of  its affiliates owes or
accepts  any  duty,  liability  or  responsibility whatsoever (whether direct or
indirect,  whether  in  contract,  in  tort,  under statute or otherwise) to any
person  who is  not a  client of  Lazard &  Co., Limited in connection with this
announcement, any statement contained herein or otherwise.

In  connection  with  the  contemplated  IPO,  the  Managers  and  any  of their
affiliates,  acting as  investors for  their own  accounts, may subscribe for or
purchase  securities and in  that capacity may  retain, purchase, sell, offer to
sell  or otherwise deal for their own  accounts in such securities and any other
securities  of  the  Company  or  related  investments  in  connection  with the
contemplated  IPO or otherwise. Accordingly,  references to the securities being
issued,  offered, subscribed, acquired,  placed or otherwise  dealt in should be
read  as including any issue or  offer to, or subscription, acquisition, placing
or  dealing by, the  Managers and any  of their respective  affiliates acting as
investors  for their own  accounts. The Managers  do not intend  to disclose the
extent  of any such investment or transactions otherwise than in accordance with
any legal or regulatory obligations to do so.

None  of  the  Managers,  Lazard  &  Co.  Limited  nor  any  of their respective
directors,  officers,  employees,  affiliates,  advisers  or agents or any other
person accepts any responsibility, duty or liability whatsoever for or makes any
representation  or warranty,  express or  implied, as  to the truth, accuracy or
completeness  or fairness  of the  information or  opinions in this document (or
whether  any  information  has  been  omitted  from  the  document) or any other
information   relating   to  the  Company,  its  shareholders,  subsidiaries  or
associated  companies, whether written, oral or  in a visual or electronic form,
and  howsoever transmitted or  made available or  for any loss howsoever arising
from any use of this document or its contents or otherwise arising in connection
therewith.

Certain figures contained in this document, including financial information,
have been subject to rounding adjustments. Accordingly, in certain instances,
the sum or percentage change of the numbers contained in this document may not
conform exactly with the total figure given.

[]